Back

prof. dr. M. (Miriam) Koopman

prof. dr. M. (Miriam) Koopman

Full Professor

Show full profile

Research Output (219)

19F MRSI of capecitabine in the liver at 7T using broadband transmit-receive antennas and dual-band RF pulses

van Gorp Sjoerd, Seevinck Peter R., Andreychenko Anna, Raaijmakers AJE, Luijten Peter R., Viergever Max A., Koopman Miriam, Boer Vincent O., Klomp Dennis W J 2015, In: NMR in Biomedicine. 28 , p. 1433-1442

Real-world resource use and costs of adjuvant treatment for stage III colon cancer

van Gils C W M, de Groot S, Tan S S, Redekop W K, Koopman M, Punt C J A, Uyl-de Groot C A 2015, In: European Journal of Cancer Care. 24 , p. 321-332 12 p.

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer

Venderbosch Sabine, Van Lent-van Vliet Shannon, De Haan Anton F.J., Ligtenberg Marjolijn J., Goossens Monique, Punt Cornelis J.A., Koopman Miriam, Nagtegaal Iris D. 2015, In: PLoS ONE [E]. 10

Systemic treatment:maintenance compared with holiday

Punt Cornelis J A, Simkens Lieke H J, Koopman Miriam 2015, In: American Society of Clinical Oncology educational book . 2015 , p. 85-90 6 p.

Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3):a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Simkens Lieke H J, van Tinteren Harm, May Anne, ten Tije Albert J, Creemers Geert-Jan M, Loosveld Olaf J L, de Jongh Felix E, Erdkamp Frans L G, Erjavec Zoran, van der Torren Adelheid M E, Tol Jolien, Braun Hans J J, Nieboer Peter, van der Hoeven Jacobus J M, Haasjes Janny G, Jansen Rob L H, Wals Jaap, Cats Annemieke, Derleyn Veerle A, Honkoop Aafke H, Mol Linda, Punt Cornelis J A, Koopman Miriam 2015, In: The Lancet. 385 , p. 1843-1852 10 p.

The CAIRO4 study:The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer - a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

't Lam - Boer Jorine, Mol Linda, Verhoef Cornelis, de Haan Anton F.J., Yilmaz Mette, Punt Cornelis J.A., de Wilt Johannes H.W., Koopman Miriam 2 Oct 2014, In: BMC Cancer. 14 , p. 741-741 1 p.

Optimal duration of systemic treatment in metastatic colorectal cancer

Simkens L.H., Koopman M., Punt C.J 2014, In: Current Opinion in Oncology. 26 , p. 448-453 6 p.

Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.

van Huis-Tanja L., Kweekel D., Lu X, Franken K., Koopman M., Gelderblom H., Antonini N.F., Punt C.J., Guchelaar H.J., van der Straaten T. 2014, In: Mutation Research. Fundamental and Molecular Mechanisms of Mutagenesis. 759 , p. 37-44 8 p.

Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer

Dik V.K., Aarts M., van Grevenstein W.M.U., Koopman M., van Oijen M.G.H., Lemmens V.E., Siersema P.D. 2014, In: British Journal of Surgery. 101 , p. 1173-11182 10010 p.

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies

Venderbosch S., Nagtegaal I.D.., Maughan T.S., Smith C.G., Cheadle J.P., Fisher D., Kaplan R., Quirke P., Seymour M.T., Richman S.D., Meijer G.A., Ylstra B., Heideman D.A., de Haan A.F., Punt C.J, Koopman M. 2014, In: Clinical Cancer Research. 20 , p. 5322-5330 9 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not